Fielder P J, Thordarson G, English A, Rosenfeld R G, Talamantes F
Department of Pediatrics, Stanford University Medical School, California 94305.
Endocrinology. 1992 Jul;131(1):261-7. doi: 10.1210/endo.131.1.1377124.
The ability of normal mouse mammary epithelial cells (MECs) to express insulin-like growth factor-binding proteins (IGFBPs) was examined. MECs were isolated from day 11 pregnant mice and cultured on floating collagen gels in serum-free basal medium. After 24 h, the medium was replaced with fresh medium with/or without mouse PRL (mPRL), mouse placental lactogen-I (mPL-I), mPL-II, mouse GH (mGH), IGF-I, and IGF-II, either alone or in combinations. The MECs were cultured for an additional 5 days before collection of conditioned medium (CM). The relative amount of IGFBPs present in the CM was determined by Western ligand blotting, and alpha-lactalbumin content was determined with a specific RIA. The CM of the MECs contained two IGFBPs, with approximate mol wt of 29K and 40-45K. The 40-45K IGFBP appears to be the mouse equivalent of IGFBP-3, but the identity of the 29K IGFBP is not presently known. The 29K IGFBP was not N-glycosylated and did not cross-react with antiserum to rodent IGFBP-2 or human IGFBP-1. Basal IGFBP expression was very low, but the addition of mPL-I, or mPL-II stimulated a marked increase in the amount of 29K IGFBP that was released into the CM and a lesser increase in the release of IGFBP-3. This increase in the release of 29K IGFBP was dose dependent, with increases found at concentrations as low as 1 ng/ml lactogen. mGH also stimulated the release of 29K IGFBP, but was less potent than any of the three lactogens. Treatment of MECs with either IGF-I or IGF-II increased the amount of both the 29K IGFBP and IGFBP-3 in the CM, with relative potencies similar to those of the lactogenic hormones. However, when either IGF-I or IGF-II was added together with one of the lactogenic hormones, the release of 29K IGFBP was increased in an additive manner. While the IGFs acted additively with the lactogenic hormones on the expression of 29K IGFBP, they did not stimulate alpha-lactalbumin production by the MECs or act to enhance the effects of the lactogenic hormones in stimulating alpha-lactalbumin production. This study demonstrates that IGFBPs are expressed in normal mouse MECs, and the release of these IGFBPs into the CM is hormonally regulated by both lactogenic hormones and IGFs.
研究了正常小鼠乳腺上皮细胞(MECs)表达胰岛素样生长因子结合蛋白(IGFBPs)的能力。从妊娠第11天的小鼠中分离出MECs,并在无血清基础培养基中的漂浮胶原凝胶上培养。24小时后,将培养基替换为添加或不添加小鼠催乳素(mPRL)、小鼠胎盘催乳素-I(mPL-I)、mPL-II、小鼠生长激素(mGH)、胰岛素样生长因子-I(IGF-I)和胰岛素样生长因子-II(IGF-II)的新鲜培养基,这些因子可单独添加或组合添加。在收集条件培养基(CM)之前,将MECs再培养5天。通过Western配体印迹法测定CM中存在的IGFBPs的相对含量,并用特异性放射免疫分析法测定α-乳白蛋白含量。MECs的CM中含有两种IGFBPs,分子量约为29K和40 - 45K。40 - 45K的IGFBP似乎相当于小鼠的IGFBP-3,但目前尚不清楚29K IGFBP的身份。29K IGFBP不是N-糖基化的,并且与针对啮齿动物IGFBP-2或人IGFBP-1的抗血清不发生交叉反应。基础IGFBP表达非常低,但添加mPL-I或mPL-II可显著增加释放到CM中的29K IGFBP的量,而IGFBP-3的释放增加较少。29K IGFBP释放的这种增加是剂量依赖性的,在低至1 ng/ml催乳素的浓度下即可发现增加。mGH也刺激29K IGFBP的释放,但效力低于三种催乳素中的任何一种。用IGF-I或IGF-II处理MECs可增加CM中29K IGFBP和IGFBP-3的量,其相对效力与催乳素相似。然而,当IGF-I或IGF-II与一种催乳素一起添加时,29K IGFBP的释放以相加的方式增加。虽然IGF与催乳素在29K IGFBP的表达上具有相加作用,但它们不刺激MECs产生α-乳白蛋白,也不增强催乳素在刺激α-乳白蛋白产生方面的作用。这项研究表明,IGFBPs在正常小鼠MECs中表达,并且这些IGFBPs释放到CM中受到催乳素和IGF的激素调节。